Truist downgraded Sabra Health Care REIT from Buy to Hold
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/8/2026 | Buy → Hold | Truist | |
| 7/7/2026 | $21.00 | Overweight | Barclays |
| 6/23/2026 | $19.00 | Buy → Neutral | Citigroup |
| 6/17/2026 | Underperform | Raymond James | |
| 11/18/2025 | $20.00 | Neutral | UBS |
| 10/1/2025 | $20.00 | Neutral | Cantor Fitzgerald |
| 1/17/2025 | Buy → Hold | Truist | |
| 1/7/2025 | $20.00 | Mkt Perform → Mkt Outperform | JMP Securities |
Truist downgraded Sabra Health Care REIT from Buy to Hold
Barclays initiated coverage of Sabra Health Care REIT with a rating of Overweight and set a new price target of $21.00
Citigroup downgraded Sabra Health Care REIT from Buy to Neutral and set a new price target of $19.00
8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)
8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)
8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)
Sabra Health Care REIT, Inc. ("Sabra") (NASDAQ:SBRA) today announced that Darrin Smith has been appointed Sabra's Chief Investment Officer, Secretary and Executive Vice President, effective January 1, 2026. Mr. Smith succeeds Talya Nevo-Hacohen, Sabra's former Chief Investment Officer, Treasurer and Executive Vice President in connection with her retirement on December 31, 2025. From March 2020 until his appointment as Chief Investment Officer, Mr. Smith served as Sabra's Executive Vice President, Investments. Mr. Smith previously served as Senior Vice President—Senior Housing Investments at HCP, Inc. (now Healthpeak Properties, Inc.), a healthcare REIT, from January 2010 through December
Sabra Health Care REIT, Inc. ("Sabra") (NASDAQ:SBRA) today announced that Jessica Flores has been appointed Executive Vice President and Chief Accounting Officer and, in such capacity, has been designated by the Company's Board of Directors as the Company's principal accounting officer. Ms. Flores currently serves as Sabra's Senior Vice President – Finance and Controller, a position she has held since January 2022. Ms. Flores joined Sabra in March 2011 and held various leadership positions overseeing Sabra's accounting during that time. Ms. Flores has over 15 years of experience in accounting, finance and real estate investments, having previously worked for KBS Realty Advisors and Deloit
IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Katie Cusack to its Board of Directors. Ms. Cusack currently serves as Chief Operating Officer of Cornell Capital LLC, a $4 billion private investment firm with offices in New York and Hong Kong. From 2007 to 2020, Ms. Cusack served in various capacities at Credit Suisse, including Chief Operating Officer for the Investment Banking Division in both Asia Pacific and Europe, Middle East and Africa, and as the Head of Ultra-High Net Worth Coverage. Prior to joining Credit Suisse, Ms. Cusack served as a Managing Director at MTS Health Partners LP, where she provided
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced a business update detailed below. Portfolio Update Sabra has entered into letters of intent to re-tenant all of its 26 properties leased to Avamere ("Avamere"). Under the proposed transition, 22 properties would be transitioned to subsidiaries of Cascadia Healthcare ("Cascadia"), a leading diversified healthcare operator concentrated in the Pacific Northwest with approximately 80 facilities pro forma for this announcement. Founded in 2015 by CEO, Owen Hammond, who was previously the President of Signum Healthcare, a subsidiary of the Ensign Group ("Ensign") covering the entire state of California
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2026 second quarter earnings release on August 3, 2026, after the close of trading.A conference call with a simultaneous webcast to discuss the 2026 second quarter results will be held on Tuesday, August 4th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596.The webcast URL is https://events.q4inc.com/attendee/256627291. A digital replay of the call will be available on our website at www.sabrahealth.com.About SabraSabra Health Care REIT, Inc., a Maryland corporation, ope
In conjunction with upcoming investor meetings, Sabra Health Care REIT, Inc. (NASDAQ:SBRA) has issued a business update, which is available on the company's website. In addition, Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Chief Investment Officer, and Lukas Hartwich, the company's Executive Vice President of Finance, will participate in Nareit's REITweek 2026 Investor Conference June 1 – 4, 2026 at the New York Hilton Midtown in New York, New York. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trus
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced a business update detailed below. Portfolio Update Sabra has entered into letters of intent to re-tenant all of its 26 properties leased to Avamere ("Avamere"). Under the proposed transition, 22 properties would be transitioned to subsidiaries of Cascadia Healthcare ("Cascadia"), a leading diversified healthcare operator concentrated in the Pacific Northwest with approximately 80 facilities pro forma for this announcement. Founded in 2015 by CEO, Owen Hammond, who was previously the President of Signum Healthcare, a subsidiary of the Ensign Group ("Ensign") covering the entire state of California
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2026 second quarter earnings release on August 3, 2026, after the close of trading.A conference call with a simultaneous webcast to discuss the 2026 second quarter results will be held on Tuesday, August 4th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596.The webcast URL is https://events.q4inc.com/attendee/256627291. A digital replay of the call will be available on our website at www.sabrahealth.com.About SabraSabra Health Care REIT, Inc., a Maryland corporation, ope
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2026. FIRST QUARTER 2026 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2026 were as follows: Net Income: $0.16 FFO: $0.37 Normalized FFO: $0.38 AFFO: $0.39 Normalized AFFO: $0.39 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.46x Senior Housing - Leased: 1.58x Behavioral Health, Specialty Hospitals and Other: 4.00x On a year-over-year basis, same property managed senior housing Cash NOI increased 14.4% for the first quarter of 2026. In the first quarter
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)